Earnings release
Page 1
arovella THERAPEUTICS Quarterly Activities & Cash Report and 4C 30 September 2021 Arovella Therapeutics Limited ABN 35 090 987 250
Loading workspace
arovella THERAPEUTICS Quarterly Activities & Cash Report and 4C 30 September 2021 Arovella Therapeutics Limited ABN 35 090 987 250
Your watchlist and earnings event details are available after you sign in.